inside tracker
inside tracker

Exclusive video interview with Dave Asprey

We talk supplementation, neurotech, mitochondrial dysfunction, clinical scale-ups, COVID and CGM with Longevity legend: Dave Asprey

Ahead of Revolution Against Aging and Death conference, which starts today, we caught up with biohacking legend, entrepreneur and Longevity thought-leader: Dave Asprey.

Longevity.Technology: This is a great interview and worthy of 25 minutes of your time – Dave always delivers, but in this wide-ranging interview he shares thoughts on Elon Musk’s Neuralink, next-generation neurotech, CGM (continuous glucose monitoring) and we learn Dave’s top three tips for kick-starting your Longevity journey today:

inside tracker

We’ll be at RAADfest (as First Longevity): will you? Stop by our virtual booth (#515) and say ‘hi’ … PLUS: save $50 off admission by using our discount code: ‘longevity’ … boom!

inside tracker

 

 

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity, a media and finance business focused on bringing together innovators and investors to commercialise the companies that will form the Longevity economy.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
inside tracker
lumen
inside tracker
lumen

Latest articles